Research and Markets: Global H3N2 Infection Therapeutics Pipeline Review 2015 -12 Companies & 23 Drug Profiles

DUBLIN--()--Research and Markets (http://www.researchandmarkets.com/research/kvsfpj/h3n2_infection) has announced the addition of the "H3N2 Infection - Pipeline Review, H2 2015" report to their offering.

This report provides comprehensive information on the therapeutic development for H3N2 Infection, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for H3N2 Infection and special features on late-stage and discontinued projects.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Companies Involved in Therapeutics Development

  • Aphios Corporation
  • Crucell N.V.
  • CSL Limited
  • ILiAD Biotechnologies, LLC
  • Inovio Pharmaceuticals, Inc.
  • Johnson & Johnson
  • Medicago Inc.
  • Mucosis B.V.
  • NanoViricides, Inc.
  • REPLICor Inc.
  • Sarepta Therapeutics, Inc.
  • Takeda Pharmaceutical Company Limited

Drug Profiles

  • APP-0205
  • APP-309
  • Aspidasept
  • C-05
  • CR-9114
  • Gamma-Flu
  • ID-38
  • influenza [strain A/H3N2] (monovalent) vaccine
  • influenza [strain A/H3N2] vaccine
  • influenza [strains A/H1N1 + A/H3N2 + B] (trivalent) vaccine
  • influenza [strains A/H1N1 + A/H3N2 + B] (trivalent) vaccine
  • influenza [strains A/H1N1 + A/H3N2 + B] (trivalent, split virion) vaccine
  • influenza [Strains H1N1, H3N2, influenza B] (quadrivalent) virus like particle vaccine
  • influenza vaccine
  • JNJ-872
  • Monoclonal Antibody for Influenza A Infections
  • NVINF-1
  • NVINF-2
  • pertussis [strain BPZE1] vaccine
  • PNSIA-28
  • radavirsen
  • REP-9
  • Small Molecules for RSV and Influenza A Infections

For more information visit http://www.researchandmarkets.com/research/kvsfpj/h3n2_infection

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Infectious Diseases

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Infectious Diseases